Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
- 30 November 2019
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 19 (12), 1299-1311
- https://doi.org/10.1016/S1473-3099(19)30403-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2013
- Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjectsJournal of Antimicrobial Chemotherapy, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology & Infection, 2012
- A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumoniaCritical Care, 2012
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 2010
- Stratified Wilson and Newcombe Confidence Intervals for Multiple Binomial ProportionsStatistics in Biopharmaceutical Research, 2010
- Hospital-Acquired Infections Due to Gram-Negative BacteriaThe New England Journal of Medicine, 2010
- Pharmacokinetic and Pharmacodynamic Properties of MeropenemClinical Infectious Diseases, 2008
- Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumoniaDiagnostic Microbiology and Infectious Disease, 2005
- Global Epidemiology of Antimicrobial Resistance among Community-Acquired and Nosocomial Pathogens: A Five-Year Summary from the SENTRY Antimicrobial Surveillance Program (1997-2001)Seminars in Respiratory and Critical Care Medicine, 2003